what data? AGILE not so sure that will be a good thing. its pretty much priced as a fail and most likley will be a fail. James was only ever an employee he has no value. The current CEO has no stock nor the two new directors it just a bottom feed fest now. The sad thing is the drugs work and those kids need it. Maybe if they spent more money producing the drug and less on new hires.
KZIA - Banter and General Comments, page-78
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)